Regen BioPharma Inc To Present at the Emerging Growth Conference Transcript
Welcome back, everyone. Next up, we have Regen BioPharma, Inc. It trades on the OTC pink sheets under the symbol RGBP and RGBPP. It's focused on the immunology and immunotherapy space. This company is focused on rapidly advancing novel technologies through preclinical and Phase 1 and 2 clinical trials. Currently, the company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders.
Please welcome President and CEO, David Koos; as well as Harry Lander, Senior Scientific Consultant. Welcome, gentlemen.
Well, thank you. Good morning, Ana. How are you doing this morning?
I'm great. We're happy to hear you guys, so whenever you're ready for questions, call me back. I'll be here.
Okay. So I'd like to start out first with going through the itinerary
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |